hCD98/5xFAD
Nomenclature
B6.Cg-Slc3a2em1(hCD98)Tg(APPSwFlLon,PSEN1*M146L*L286V)Smoc
Cat. NO.
NMX-XA-253913
Strain State
Repository Live
Model Description
Validation Data

Fig.1 Detection of CD98 expression in 5xFAD/hCD98 mice by WB. Human CD98 was exclusively detectable in brain from 5xFAD/hCD98 mice. The brain lysates were collected from 13-week-old wild-type C57BL/6 mice and 12-week-old heterozygous/homozygous 5xFAD/hCD98 mice, and then analyzed by western blot with anti-CD98 antibody.
Abbr. HE, Heterozygous; HO, homozygous; WT, wild type; PC, positive control, Hela cells; M, marker.
Note. The mice did not undergo fasting before collecting tissues.

Table 2. Blood routine examination of 5xFAD/hCD98 mice. Blood routine parameters in 5xFAD/hCD98 knock-in mice were similar to those in wild-type C57BL/6 mice. Values are expressed as mean±SEM.
Abbr. HE, heterozygous; HO, homozygous; WT, wild type.
Note. The mice did not undergo fasting before collecting the blood samples.

Table 3. Biochemical test of serum from HE/HO 5xFAD/hCD98 knock-in mice. Values are expressed as mean±SEM.
Abbr. HE, heterozygous; HO, homozygous; WT, wild type.
Note. The mice did not undergo fasting before collecting the serum samples.

Fig.2 Biochemical test of serum from HE/HO 5xFAD/hCD98 knock-in mice. Male 5xFAD/hCD98 mice showed no significant differences in serum liver, renal, or lipid parameters or phosphorus levels compared with WT males. Female 5xFAD/hCD98 mice exhibited slightly higher serum ALT, AST, UREA, and phosphorus levels than WT females, but remained comparable to 5xFAD/hCD98 males. (Mean±SEM, Unpaired t-test, *p<0.05, **p<0.01, ns: no significance).
Abbr. HE, heterozygous; HO, homozygous; WT, wild type.
Note. The mice did not undergo fasting before collecting the serum samples.
You may also like
Workshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreShanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more